LE TCHEN: Open Payments
NPI 1043504814 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 18 payments from 9 companies in 2025. Trend: 2023 $245 · 2024 $180 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 7 | $143 |
| Paratek Pharmaceuticals, Inc. | 3 | $58 |
| Solventum Corporation | 1 | $46 |
| Organogenesis Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $30 |
| CashFlow Solutions, LLC | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Stryker Corporation | 1 | $16 |
| HARTMANN USA, INC. | 1 | $15 |
Products named: COLLAGENASE SANTYL, NUZYRA, ACTIV.A.C., TEFLARO, CYGNUS DUAL, AFFINITY, RENASYS TOUCH, LYMPHA PRESS OPTIMAL PLUS(US) BT.
Industry payments across TX — which companies pay providers there.
